JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

Search

NeoGenomics Inc

Suletud

10.63 1.82

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

10.46

Max

10.69

Põhinäitajad

By Trading Economics

Sissetulek

-19M

-45M

Müük

13M

181M

Kasumimarginaal

-24.867

Töötajad

2,200

EBITDA

-41M

-48M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+6.19% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

28. okt 2025

Turustatistika

By TradingEconomics

Turukapital

537M

1.4B

Eelmine avamishind

8.81

Eelmine sulgemishind

10.63

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

NeoGenomics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

24. okt 2025, 16:25 UTC

Suurimad hinnamuutused turgudel

Obook Shares Rise, Company Secures New Money Transmitter Licenses

23. okt 2025, 12:37 UTC

Suurimad hinnamuutused turgudel
Omandamised, ülevõtmised, äriostud

Solmate Infrastructure Shares Higher on Acquisition Plans

22. okt 2025, 16:54 UTC

Suurimad hinnamuutused turgudel

Applied DNA Sciences Shares Rise After Private Investment, Crypto Buys

21. okt 2025, 13:09 UTC

Tulu
Suurimad hinnamuutused turgudel

Galaxy Digital Shares Jump on Swing to 3Q Profit, Surging Revenue

17. okt 2025, 15:03 UTC

Suurimad hinnamuutused turgudel

Obook Shares Sink Following Public Debut

24. okt 2025, 13:16 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

24. okt 2025, 13:16 UTC

Market Talk

Bitcoin Rises After U.S. Inflation Data Firms Rate Cut Bets -- Market Talk

24. okt 2025, 06:59 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

24. okt 2025, 06:59 UTC

Market Talk

Bitcoin Rises on Confirmation of Trump-Xi Meeting -- Market Talk

23. okt 2025, 07:04 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23. okt 2025, 07:04 UTC

Market Talk

Bitcoin Edges Higher But U.S.-China Tensions Limit Recovery -- Market Talk

22. okt 2025, 14:05 UTC

Market Talk

Bitcoin Could Briefly Fall Below $100K -- Market Talk

22. okt 2025, 09:30 UTC

Omandamised, ülevõtmised, äriostud

Combination of FalconX, 21Shares to Develop Derivatives, Structured Products -- WSJ

22. okt 2025, 09:30 UTC

Omandamised, ülevõtmised, äriostud

Crypto Trading Firm FalconX to Buy ETF Manager 21Shares -- WSJ

22. okt 2025, 09:30 UTC

Omandamised, ülevõtmised, äriostud

FalconX to Fund 21Shares Deal Using Cash, Stock -- WSJ

22. okt 2025, 09:30 UTC

Omandamised, ülevõtmised, äriostud

FalconX Strikes Deal to Buy Crypto Asset Manager 21Shares -- WSJ

22. okt 2025, 07:57 UTC

Market Talk

Bitcoin Falls After Confusing U.S.-China Signals -- Market Talk

21. okt 2025, 10:00 UTC

Omandamised, ülevõtmised, äriostud

Deal Set to Come Later Tuesday, Executives Say -- WSJ

21. okt 2025, 10:00 UTC

Omandamised, ülevõtmised, äriostud

Coinbase Strikes Deal for Crypto-Investing Platform Echo -- WSJ

21. okt 2025, 10:00 UTC

Omandamised, ülevõtmised, äriostud

Coinbase Strikes Roughly $375M Deal for Crypto-Investing Platform Echo, Executives Say -- WSJ

21. okt 2025, 10:00 UTC

Omandamised, ülevõtmised, äriostud

Coinbase to Fund Deal Using Cash and Stock, Executives Say -- WSJ

21. okt 2025, 08:00 UTC

Market Talk

Bitcoin Falls as Recovery Attempts Prove Short-Lived -- Market Talk

20. okt 2025, 14:30 UTC

Omandamised, ülevõtmised, äriostud

Evernorth to Raise Over $1B in SPAC Deal with Armada II

20. okt 2025, 07:03 UTC

Market Talk

Bitcoin Rises on Hopes For De-Escalation in U.S.-China Tensions -- Market Talk

17. okt 2025, 10:37 UTC

Market Talk

Bitcoin Extends Losses as Investors Shun Risky Assets -- Market Talk

17. okt 2025, 07:08 UTC

Market Talk

Bitcoin Falls as U.S. Regional Bank Concerns, U.S.-China Tensions Weigh -- Market Talk

16. okt 2025, 19:37 UTC

Omandamised, ülevõtmised, äriostud

Crypto Industry Dives Deeper Into Prediction Markets as Kraken Buys Exchange -- Barrons.com

16. okt 2025, 18:31 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16. okt 2025, 18:31 UTC

Market Talk

Global Equities Roundup: Market Talk

16. okt 2025, 18:31 UTC

Market Talk

Charles Schwab Readies Spot Crypto Trading -- Market Talk

Võrdlus sarnastega

Hinnamuutus

NeoGenomics Inc Prognoos

Hinnasiht

By TipRanks

6.19% tõus

12 kuu keskmine prognoos

Keskmine 11.33 USD  6.19%

Kõrge 14 USD

Madal 8 USD

Põhineb 10 Wall Streeti analüütiku instrumendi NeoGenomics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

10 ratings

5

Osta

5

Hoia

0

Müü

Tehniline skoor

By Trading Central

7.7 / 10.27Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bearish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
help-icon Live chat